ALLO

ALLO EBITDA Margin

-3287.20%TTM

Period ending:

ALLO FY EBITDA Margin%
ALLO FY EBITDA Margin132723.82%-1238755.64%
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

ALLO ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

Allogene Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
0%
-1,106,031.8182%
-329,543.1579%
-209,050.641%
-150.4063%
0%
0%
0%
0%

Compare ebitda margin

All ALLO financial metrics · ALLO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.